000 01061nam a2200301 a 4500
005 20250914131013.0
008 030911s2003 xxua b 001 0 eng b
020 _a158890119X (TNY)
_cRM37.68
020 _a313125811X
039 9 _a200609280924
_bruzini
_c200609271221
_druzini
_c200408101125
_dlailawati
_c200405061454
_y09-11-2003
_zdiyana
060 _aWW270
_b.C6415 2003
090 _aWW270.C6415 2003
245 0 0 _aClinical pathways in vitreoretinal disease /
_c[edited by] Scott M. Steidl, Mary Elizabeth Hartnett
260 _aNew York :
_bThieme,
_c2003
300 _axiv, 442 p. :
_bill. ;
_c28 cm.
650 2 _aVitreoretinopathy, Proliferative
650 2 _aCritical Pathways
700 1 _aSteidl, Scott,
_d1956-
700 1 _aHartnett, Mary Elizabeth
907 _a.b13258710
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWW270.C6415 2003
914 _avtls000340354
990 _azh
991 _aJabatan Oftalmologi, HUKM
991 _aOptometri, KKL
998 _a(2)d
_ah
_b2003-11-09
_cm
_da
_feng
_gxxu
_y0
_z.b13258710
999 _c325376
_d325376